Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
5.68
-0.22 (-3.73%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Acelyrin Market Cap

Acelyrin has a market cap or net worth of $566.91 million as of October 31, 2024. Its market cap has decreased by -42.67% in one year.

Market Cap
566.91M
Enterprise Value
-45.06M
1-Year Change
-42.67%
Ranking
Category
Stock Price
$5.68

Market Cap Chart

Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $566.91M, a decrease of -66.02%. That is a compound annual growth rate of -51.53%.

History

DateMarket Cap% Change
Oct 30, 2024588.90M-18.91%
Dec 29, 2023726.20M-56.48%
View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CureVac 624.71M
Revance Therapeutics 621.08M
Savara 619.72M
Tango Therapeutics 618.76M
CorMedix 615.73M
Fulgent Genetics 609.57M
Entrada Therapeutics 607.68M
Third Harmonic Bio 599.20M
Market Cap Rankings